A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder (2011)
- Authors:
- USP affiliated authors: PEREIRA, CARLOS ALBERTO DE BRAGANCA - IME ; MIGUEL FILHO, EURIPEDES CONSTANTINO - FM ; FOSSALUZA, VICTOR - IME
- Unidades: IME; FM
- DOI: 10.1097/JCP.0b013e3182367aee
- Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA); CO-TERAPIA; FÁRMACOS SINTÉTICOS; ANTIPSICÓTICOS
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2011
- Source:
- Título: Journal of Clinical Psychopharmacology
- ISSN: 0271-0749
- Volume/Número/Paginação/Ano: v. 31, n. 6, p. 763-768, 2011
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
DINIZ, Juliana Belo et al. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, v. 31, n. 6, p. 763-768, 2011Tradução . . Disponível em: https://doi.org/10.1097/JCP.0b013e3182367aee. Acesso em: 31 mar. 2026. -
APA
Diniz, J. B., Shavitt, R. G., Fossaluza, V., Koran, L., Pereira, C. A. de B., & Miguel, E. C. (2011). A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 31( 6), 763-768. doi:10.1097/JCP.0b013e3182367aee -
NLM
Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA de B, Miguel EC. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder [Internet]. Journal of Clinical Psychopharmacology. 2011 ; 31( 6): 763-768.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1097/JCP.0b013e3182367aee -
Vancouver
Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA de B, Miguel EC. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder [Internet]. Journal of Clinical Psychopharmacology. 2011 ; 31( 6): 763-768.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1097/JCP.0b013e3182367aee - Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- A double-blind randomized controlled trial of fluoxetine plus quetiapine or clomipramine vs. Fluoxetine plus placebo for obsessive-compulsive disorder
- Trajectory in obsessive-compulsive disorder comorbidities
- Validation of the University of Sao Paulo Sensory Phenomena Scale: Initial Psychometric Properties
- Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states?
- Perinatal risk factors and obsessive-compulsive spectrum disorders in patients with rheumatic fever
- Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial
- Comorbid major depression in obsessive-compulsive disorder patients
- Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
